1. Home
  2. SGD vs CPHI Comparison

SGD vs CPHI Comparison

Compare SGD & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGD
  • CPHI
  • Stock Information
  • Founded
  • SGD 2021
  • CPHI N/A
  • Country
  • SGD United States
  • CPHI China
  • Employees
  • SGD N/A
  • CPHI N/A
  • Industry
  • SGD
  • CPHI Biotechnology: Pharmaceutical Preparations
  • Sector
  • SGD
  • CPHI Health Care
  • Exchange
  • SGD Nasdaq
  • CPHI Nasdaq
  • Market Cap
  • SGD 4.4M
  • CPHI 4.7M
  • IPO Year
  • SGD N/A
  • CPHI N/A
  • Fundamental
  • Price
  • SGD $1.19
  • CPHI $1.81
  • Analyst Decision
  • SGD
  • CPHI
  • Analyst Count
  • SGD 0
  • CPHI 0
  • Target Price
  • SGD N/A
  • CPHI N/A
  • AVG Volume (30 Days)
  • SGD 575.0K
  • CPHI 16.1K
  • Earning Date
  • SGD 11-22-2025
  • CPHI 11-12-2025
  • Dividend Yield
  • SGD N/A
  • CPHI N/A
  • EPS Growth
  • SGD N/A
  • CPHI N/A
  • EPS
  • SGD N/A
  • CPHI N/A
  • Revenue
  • SGD $1,536,255.00
  • CPHI $4,396,201.00
  • Revenue This Year
  • SGD N/A
  • CPHI N/A
  • Revenue Next Year
  • SGD N/A
  • CPHI N/A
  • P/E Ratio
  • SGD N/A
  • CPHI N/A
  • Revenue Growth
  • SGD 1570.24
  • CPHI N/A
  • 52 Week Low
  • SGD $0.65
  • CPHI $1.20
  • 52 Week High
  • SGD $3.86
  • CPHI $3.35
  • Technical
  • Relative Strength Index (RSI)
  • SGD 45.51
  • CPHI 47.26
  • Support Level
  • SGD $1.05
  • CPHI $1.81
  • Resistance Level
  • SGD $1.65
  • CPHI $1.93
  • Average True Range (ATR)
  • SGD 0.20
  • CPHI 0.08
  • MACD
  • SGD -0.03
  • CPHI -0.02
  • Stochastic Oscillator
  • SGD 23.33
  • CPHI 5.00

About SGD Safe and Green Development Corporation

Safe & Green Development Corp is a real estate development company that focuses on the development of sites using purpose built, prefabricated modules built from both wood & steel, sourced from one of Safe and Green Holdings factories. The company's business model is flexible and it anticipates developing properties on its own and also through joint ventures in which it partners with third-party equity investors or other developers.

About CPHI China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.

Share on Social Networks: